AROG Pharmaceuticals
Manufacturing · Texas, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
2700 W Plano Pkwy, Plano, Texas, 75075, ...Phone Number
(214) 593-0500Website
www.arogpharma.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
2
1
1
1
1
About AROG Pharmaceuticals
Arog Pharmaceuticals is focused on advancing Crenolanib, a Phase III-ready FLT3 inhibitor designed for post-allogeneic hematopoietic stem cell transplantation maintenance in high-risk acute myeloid leukemia (AML) patients. The company has successfully treated over 400 patients with this innovative therapy. Their primary clients include healthcare providers and institutions involved in the treatment of high-risk AML. Arog Pharmaceuticals aims to improve outcomes for patients facing this challenging condition.Explore more
AROG Pharmaceuticals Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is AROG Pharmaceuticals your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Product Launch: Get notified when AROG Pharmaceuticals launches new products
Website visits: Recent activity has been detected on your website
Click to see if AROG Pharmaceuticals had a recent Job posting/layoffs
Congratulate Masked Content for being promoted to Masked Content at AROG Pharmaceuticals
Check if AROG Pharmaceuticals has recently received funding, and reach out quickly before it becomes old news!
Earning: See what the market has to say on AROG Pharmaceuticals recently announced quarterly report
AROG Pharmaceuticals, which may be a good buyer, showed buying intent in Masked Content Topic
Check out if AROG Pharmaceuticals is spiking on competitors!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Funding: Get notified immidiatlly once AROG Pharmaceuticals has new funding data
Recommended Actions
Reach out to Masked Content who joined AROG Pharmaceuticals as Masked Content
Find more new buyers
Compare Similar Companies to AROG Pharmaceuticals
Compare insights from companies similar to AROG Pharmaceuticals, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
AROG Pharmaceuticals is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
AROG Pharmaceuticals is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about AROG Pharmaceuticals.
AROG Pharmaceuticals Tech Stack
A closer look at the technologies used by AROG Pharmaceuticals
See more technologies
Most Recent Scoops
Project
Laboratory Operations, Medical Research, Clinical Operations
Project
Laboratory Operations, Medical Research, Clinical Operations
Promotion
Executive Move
Amitkumar Patel has recently been promoted from Director, Clinical Operations to the role of Chief Operating Officer.
Executive Moves, Promotion
Promotion
Executive Move
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding AROG Pharmaceuticals
Sign Up For FreeTo access detailed company insights
Arog Pharmaceuticals is focused on advancing Crenolanib, a Phase III-ready FLT3 inhibitor designed for post-allogeneic hematopoietic stem cell transplantation maintenance in high-risk acute myeloid leukemia (AML) patients. The company has successfully treated over 400 patients with this innovative therapy. Their primary clients include healthcare p... Read More
